Results 171 to 180 of about 67,833 (224)

Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence. [PDF]

Proc Natl Acad Sci U S A
Yamaoka S, M'Hamdi Z, Wang L, Swenson VA, McNally KL, Lu SC, Singh R, Saundh SL, Zell BN, Best SM, Barry MA, Rasmussen AL, Ebihara H.   +12 more
europepmc   +1 more source

Long-term Sequelae in Ebola Virus Disease Survivors Receiving Anti-Ebola Virus Therapies in the Democratic Republic of the Congo: A Prospective Cohort Study. [PDF]

Open Forum Infect Dis
Dilu-Keti A, Tovar-Sanchez T, Cuer B, Nkuba-Ndaye A, Mukadi-Bamuleka D, Panzi-Kalunda E, Kitenge-Omasumbu R, Bulabula-Penge J, Mambu-Mbika F, Mbala-Kingebeni P, Ayouba A, Muyembe-Tamfum JJ, Etard JF, Chenge F, Delaporte E, Ahuka-Mundeke S, ‘Les Vainqueurs d’Ebola’ study group .   +16 more
europepmc   +1 more source

Small molecule drug discovery for Ebola virus disease. [PDF]

RSC Med Chem
Durante D, Murugesh V, Kalanquin T, Gaisina IN, Rong L, Moore TW.   +5 more
europepmc   +1 more source

Phylogenetic analysis of initial Ebola virus genomes from the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo, September 2025

Wawina-Bokalanga T, Amuri A, Luakanda G, Makangara-Cigolo J, Kinganda-Lusamaki E, Ngandu C, Bula-Loso S, Mossoko M, Tshulo L, Akil-Bandali P, Kitenge R, Brosius I, Lokilo E, Kimbonza S, Paku-Tshambu P, Ngonda-Tshibinda A, Kuispond-Swar N, Ayouba A, Nsio J, Mbantshi-Beya J, Cikaya-Kankolongo F, Ntumba-Tshitenge O, Keita M, Mukadi P, Mukadi-Bamuleka D, Tshiani-Mbaya O, Mulangu S, Quick J, Loman N, O’Toole Á, Mwamba D, Delaporte E, Hensley L, Rimoin A, Wilkinson S, Peeters M, Ahuka-Mundeke S, Liesenborghs L, Kindrachuk J, Low N, Carroll M, Maes P, Vercauteren K, Muyembe-Tamfum J, Kuppalli K, Rambaut A, Wawina-Bokalanga T, Mbala P.   +47 more
europepmc   +1 more source

Platelet-like particles released from Ebola virus-infected megakaryocytic cells behave like virus-like particles. [PDF]

PLoS Pathog
Kuroda M, Halfmann PJ.
europepmc   +1 more source

Long-term psychosocial sequelae of Ebola virus disease among survivors compared with contacts following the 2013-2016 epidemic in Liberia. [PDF]

PLOS Glob Public Health
Badio M, Glayweon M, Van Ryn C, Wilson B, Cooper JB, Moses JS, Fayiah T, Johnson K, Gayedyu-Dennis D, Chitre SD, Richardson ET, Reilly C, Weiser SD, Rutherford GW, Fallah MP, Kelly JD.   +15 more
europepmc   +1 more source

Correction: Spatial modeling and ecological suitability of Ebola virus disease in Africa. [PDF]

PLoS One
Didier LB, Jude LL, Franck EI, Wang H, Wang XL.   +4 more
europepmc   +1 more source

Infection-sensing minigenome as a novel therapeutic approach against Ebola virus. [PDF]

Mol Ther Nucleic Acids
Wang L, Zell BN, Parrett BJ, Barry MA, Yamaoka S.   +4 more
europepmc   +1 more source

Oral immunization with filovirus-like particles partially protects IFNAR^-/^- mice against lethal ebola virus challenge. [PDF]

Sci Rep
Escudero-Pérez B, Lasala F, Luczkowiak J, Labiod N, Rivas G, Morgado H, Casasnovas JM, Nave J, Wurr S, García-Bernalt Diego J, Muñoz-Fontela C, Delgado R.   +11 more
europepmc   +1 more source

Identification of novel small chemical compounds that inhibit Ebola virus VP40-mediated virus-like particle production. [PDF]

Virus Res
Tsuruta T, Mizuta S, Izumisawa A, Yasuda J, Urata S.   +4 more
europepmc   +1 more source